tbuckley/cabot-search huggingface dataset:
Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With<i>NPM1</i>Mutation: A Study by the Acute Leukemia French Association Group
Authors: Marie Balsat, Aline Renneville, Xavier Thomas, Stéphane de Botton, Denis Caillot, Alice Marceau, Emilie Lemasle, Jean-Pierre Marolleau, Olivier Nibourel, Céline Berthon, Emmanuel Raffoux, Arnaud Pigneux, Céline Rodriguez, Norbert Vey, Jean-Michel Cayuela, Sandrine Hayette, Thorsten Braun, Marie Magdeleine Coudé, Christine Terre, Karine Celli-Lebras, Hervé Dombret, Claude Preudhomme, Nicolas Boissel
Journal: Journal of Clinical Oncology (2017)

Purpose This study assessed the prognostic impact of postinduction NPM1-mutated ( NPM1m) minimal residual disease (MRD) in young adult patients (age, 18 to 60 years) with acute myeloid leukemia, and addressed the question of whether NPM1m MRD may be used as a predictive factor of allogeneic stem cell transplantation (ASCT) benefit. Patients and Methods Among 229 patients with NPM1m who were treated in the Acute Leukemia French Association 0702 (ALFA-0702) trial, MRD evaluation was available in 152 patients in first remission. Patients with nonfavorable AML according to the European LeukemiaNet (ELN) classification were eligible for ASCT in first remission. Results After induction therapy, patients who did not achieve a 4-log reduction in NPM1m peripheral blood-MRD (PB-MRD) had a higher cumulative incidence of relapse (subhazard ratio [SHR], 5.83; P < .001) and a shorter overall survival (OS; hazard ratio [HR], 10.99; P < .001). In multivariable analysis, an abnormal karyotype, the presence of FLT3-internal tandem duplication (ITD), and a < 4-log reduction in PB-MRD were significantly associated with a higher relapse incidence and shorter OS. In the subset of patients with FLT3-ITD, only age, white blood cell count, and < 4-log reduction in PB-MRD, but not FLT3-ITD allelic ratio, remained of significant prognostic value. In these patients with nonfavorable AML according to European LeukemiaNet, disease-free survival and OS were significantly improved by ASCT in those with a < 4-log reduction in PB-MRD. This benefit was not observed in those with a > 4-log reduction in PB-MRD, with a significant interaction between ASCT effect and PB-MRD response ( P = .024 and .027 for disease-free survival and OS, respectively). Conclusion Our study supports the strong prognostic significance of early NPM1m PB-MRD, independent of the cytogenetic and molecular context. Moreover, NPM1m PB-MRD may be used as a predictive factor for ASCT indication.
To stress or not to stress? Exercise pulmonary haemodynamic testing in systemic sclerosis
Authors: Edmund M.T. Lau, Vivek Thakkar, Marc Humbert, Philippe Herve
Journal: European Respiratory Journal (2016)

Pulmonary arterial hypertension (PAH) is a leading cause of morbidity and mortality in systemic sclerosis (SSc) [1], and patients have a ∼10% lifetime risk of developing this devastating complication [2]. Despite targeted PAH therapy, outcomes of SSc-associated PAH (SSc-PAH) remain unsatisfactory, with a median survival of only 3–4 years from time of diagnosis [3, 4]. In the hope of further improving outcomes in SSc-PAH, early disease detection has been a major focus of research in the past decade [5–9]. One important and highly debated topic is the utility of exercise pulmonary haemodynamic testing for the early diagnosis of pulmonary vascular disease [10–12]. Exercise pulmonary hypertension may have prognostic significance in patients with systemic sclerosis <http://ow.ly/qkpx304uPZE>
ABCChips as New Diagnostic Tool to Monitoring Multidrug Resistance in Human Tumor Cells to Chemotherapeutics Agents by Expression Profiling of ATP-Binding Cassette Transporter Genes.
Authors: Jean-Pierre Gillet, Thomas Efferth, Damiel Steinbach, Françoise de Longueville, Vincent Bertholet, José Remacle, Herbert G. Sayer
Journal: Blood (2004)
Epidemiology of traumatic brain injuries in Europe: a cross-sectional analysis
Authors: Marek Majdan, Dominika Plancikova, Alexandra Brazinova, Martin Rusnak, Daan Nieboer, Valery Feigin, Andrew Maas
Journal: The Lancet Public Health (2016)

IntroductionTraumatic brain injuries (TBI) are a major medical and socioeconomic problem. We aimed to estimate the hospital-based incidence, population-wide mortality, and the contribution of TBI to injury-related mortalities in European countries, and to provide European summary estimates for these indicators.MethodsFor this cross-sectional analysis, we obtained population data from Eurostat for hospital discharges and causes of death in European countries in 2012. Outcomes of interest were TBIs that required hospital admission or were fatal. We calculated age-adjusted hospital discharge rates and mortality rates and extrapolated data to 28 European Union countries and all 48 states in Europe. We present between-country comparisons, pooled age-adjusted rates, and comparisons with all-injury rates.FindingsIn 2012, 1 375 974 hospital discharges (data from 24 countries) and 33 415 deaths (25 countries) related to TBI were identified. The pooled age-adjusted hospital discharge rate was 287·2 per 100 000 (95% CI 232·9–341·5) and the pooled age-adjusted mortality rate was 11·7 per 100 000 (9·9–13·6). TBI caused 37% (95% CI 36–38) of all injury-related deaths in the analysed countries. Extrapolating our results, we estimate 56 946 (95% CI 47 286–66 099) TBI-related deaths and 1 445 526 (1 172 996–1 717 039) hospital discharges occurred in 2012 in the European Union (population 508·5 million) and about 82 000 deaths and about 2·1 million hospital discharges in the whole of Europe (population 737 million). We noted substantial between-country differences.InterpretationTBI is an important cause of death and hospital admissions in Europe. The substantial between-country differences observed warrant further study and suggest that the true burden of TBI in Europe has not yet been captured. Rigorous epidemiological studies are needed to fully quantify the effect of TBI on society. Despite a great degree of consistency in data reporting across countries already being achieved, further efforts in this respect could improve the validity of between-country comparisons.FundingEuropean Union, FP7.
Bortezomib (VELCADE), Rituximab, Cyclophosphamide, Dexamethasone (VRCD) Combination Therapy In Front-Line Low-Grade Non-Hodgkin Lymphoma (LG-NHL) Is Active In Elderly Patient Population
Authors: Chadi Nabhan, Neil Dalal, Kathy Tolzien, Alexander Starr
Journal: Blood (2010)
Pharmacokinetic Dose Guidance of IV Busulfan with Fludarabine with Allogeneic Stem Cell Transplantation Improves Progression Free Survival in Patients with AML and MDS; Results of a Randomized Phase III Study
Authors: Borje S Andersson, Marcos J de Lima, Rima M Saliba, Elizabeth J Shpall, Uday Popat, Roy Jones, Yago Nieto, Chitra M Hosing, Partow Kebriaei, Amin M Alousi, Laura L. Worth, Timothy Madden, Alison Gulbis, Julianne J Chen, Gabriela Rondon, Patricia McAdams, Becky McMullin, Michael Andreeff, Richard Champlin
Journal: Blood (2011)
Efficacy of ICT with Deferasirox in Transfusional Iron Overloaded Patients with MDS or AA.
Authors: June-Won Cheong, Hyeoung-Joon Kim, Kyoo-Hyung Lee, Sung-Soo Yoon, Jae Hoon Lee, Hee-Sook Park, Jin Seok Kim, Ho Young Kim, Hyeok Shim, Chu-Myung Seung, Chul Soo Kim, Jooseop Chung, Myung Soo Hyun, Deog-Yeon Jo, Chul Won Jung, Sang Kyun Sohn, Hwi-Joong Yoon, Byung Soo Kim, Young-Don Joo, Chi-Young Park, Yoo-Hong Min
Journal: Blood (2009)
Erratum: Corrigendum: Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults
Authors: Takahiko Yasuda, Shinobu Tsuzuki, Masahito Kawazu, Fumihiko Hayakawa, Shinya Kojima, Toshihide Ueno, Naoto Imoto, Shinji Kohsaka, Akiko Kunita, Koichiro Doi, Toru Sakura, Toshiaki Yujiri, Eisei Kondo, Katsumichi Fujimaki, Yasunori Ueda, Yasutaka Aoyama, Shigeki Ohtake, Junko Takita, Eirin Sai, Masafumi Taniwaki, Mineo Kurokawa, Shinichi Morishita, Masashi Fukayama, Hitoshi Kiyoi, Yasushi Miyazaki, Tomoki Naoe, Hiroyuki Mano
Journal: Nature Genetics (2016)
A Cell-Based Adhesion Molecule Bioassay Detects Unexpected Properties of Plasma From Patients with Sickle Cell Disease with Documented Pulmonary Hypertension
Authors: Antje Ask, Laurel G. Mendelsohn, Shoaib Alam, Alem Mehari, Caterina Minniti, James G. Taylor, Gregory J. Kato
Journal: Blood (2011)
Remembering Johnnie
Authors: Katherine C. Chretien
Journal: Annals of Internal Medicine (2014)

On Being a Doctor15 July 2014Remembering JohnnieKatherine C. Chretien, MDKatherine C. Chretien, MDFrom Washington DC Veterans Affairs Medical Center, Washington, DC.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/M14-0086 Audio Reading - “Remembering Johnnie” Audio. Michael A. LaCombe, MD, Annals Associate Editor, reads "Physical Diagnosis," by J. Coulehan. Your browser does not support the audio element. Audio player progress bar Step backward in current audio track Play current audio trackPause current audio track Step forward in current audio track Mute current audio trackUnmute current audio track 00:00/ SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Driving on unfamiliar roads in Southeast DC, I thought about how much greener it was out here than I had imagined. Southeast is a part of DC with higher crime and poverty than most areas of the district. I guess I was expecting something grittier and less yielding than the leafy boughs framing neat storefronts and the occasional gas station.It was midday on a spring Wednesday, my pager was on, and I had to be back at the hospital later to check in with my resident team. Now I was on a mission to find a funeral home.I ... Author, Article, and Disclosure InformationAffiliations: From Washington DC Veterans Affairs Medical Center, Washington, DC.Corresponding Author: Katherine C. Chretien, MD, Washington DC Veterans Affairs Medical Center, 50 Irving Street NW, Medical Service (111), Washington, DC 20422; e-mail, Katherine.[email protected]gov. PreviousarticleNextarticle Advertisement Audio Reading - “Remembering Johnnie” Audio. Michael A. LaCombe, MD, Annals Associate Editor, reads "Physical Diagnosis," by J. Coulehan. Your browser does not support the audio element. Audio player progress bar Step backward in current audio track Play current audio trackPause current audio track Step forward in current audio track Mute current audio trackUnmute current audio track 00:00/ FiguresReferencesRelatedDetails Metrics 15 July 2014Volume 161, Issue 2Page: 155-156KeywordsAfrican American peopleBlood pressureCombined antiretroviral therapyEmergency departmentEmotionsNursesSleepThermometersThoraxTriage ePublished: 15 July 2014 Issue Published: 15 July 2014 Copyright & PermissionsCopyright © 2014 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
CAL-101 (GS-1101), a Specific Inhibitor of Phosphatidylinositol-3-Kinase-Delta (PI3Kδ), Disrupts Signals From the Microenvironment, Induces Apoptosis, and Enhances the Antitumor Activity of Everolimus (RAD001), An Inhibitor of Mammalian Target of Rapamycin (mTOR), in Mantle Cell Lymphoma (MCL),
Authors: Sarah A Meadows, Adam Kashishian, David Johnson, Roger G Ulrich, Langdon L Miller, Brian J. Lannutti
Journal: Blood (2011)
Favorable Clinical Outcome and Unique Characteristics in Association with Twist1 overexpression in De Novo Acute Myeloid Leukemia
Authors: Cih-En Huang, Chih-Cheng Chen, Jyh-Pyng Gau, Jie-Yu You, Yi-Yang Chen, Hui-Ju Chou, Jrhau Lung, Muh-Hwa Yang
Journal: Blood (2014)
Inherited Mutation in Exon 2 of GATA-1 Is Associated with a Clinical and Laboratory Picture Similar to Familial Hypocellular Myelodysplastic Syndrome (MDS).
Authors: Luciana M. Hollanda, Carmen S.P. Lima, Anderson F. Cunha, Dulcineia M. Albuquerque, Margareth C. Ozelo, Carmino A. De Souza, Irene Lorand-Metze, Sara T.O. Saad, Fernando F. Costa
Journal: Blood (2004)
Cardiac Transplant Followed by High-Dose Melphalan and Autologous Stem Cell Transplantation (ASCT) for Patients with AL Amyloidosis and Severe Heart Failure.
Authors: Bimalangshu R. Dey, Thomas R. Spitzer, Thomas E. MacGillivray, Stephen S. Chung, G.W. Dec, David C. Seldin, Steven L. McAfee, Karen Ballen, Eyal Attar, Martha Skinner, Joren C. Madsen, Marc J. Semigran
Journal: Blood (2007)
A Vector Expressing PML-RARα Fused to GM-CSF Is an Effective DNA Vaccine for Inducing Specific Immune Response to APL Cells.
Authors: Yangqiu Li, Dongzhi Cen, Gang Hu, Yubing Zhou, Shaohua Chen, Lijian Yang, Grzegorz K. Przybylski, Christian A. Schmidt
Journal: Blood (2007)
Rearrangements of IER3 Represent a Novel and Recurrent Molecular Abnormality in Myelodysplastic Syndromes (MDS)
Authors: David P. Steensma, Jessemy D Neiger, Julie C Porcher, J. Jonathan Keats, Peter Leif Bergsagel, Ryan A Knudson, Rafael Santana-Davila, Rajiv Kumar, Rhett Ketterling
Journal: Blood (2008)
The CALM/AF10 Interactor CATS Is a Substrate of KIS, a Positive Regulator of Cell Cycle Progression in Leukemia Cells
Authors: Leticia Fröhlich Archangelo, Fabíola Traina, Philipp A Greif, Alexandre Maucuer, Valérie Manceau, Carolina Bigarella, Marcos Tadeu dos Santos, Jörg Kobarg, Stefan K Bohlander, Sara T Olalla Saad
Journal: Blood (2011)
Inhibition of Bcl-2/Bcl-XL Promotes Apoptosis in Blast Crisis CML Including Quiescent Primitive Progenitor Cells Regardless of Cellular Responses to Tyrosine Kinase Inhibitors.
Authors: Duncan H. Mak, Wendy D. Schober, Marina Konopleva, Jorge Cortes, Hagop M. Kantarjian, Michael Andreeff, Bing Z. Carter
Journal: Blood (2009)
Early Autologous Stem Cell Transplantation (SCT) in Genetically Poor-Risk Chronic Lymphocytic Leukemia Is Feasible and Effective: Results from a Prospective Multicenter Study (GCLLSG CLL3 Protocol).
Authors: Peter Dreger, Raimonde Busch, Stephan Stilgenbauer, Hildegard Greinix, Manfred Hensel, Bernd Hertenstein, Ulrich Duehrsen, Marcus Hentrich, Lorenz H. Truemper, Norbert Schmitz, Matthias Ritgen, Bertold Emmerich, Michael J. Hallek, Michael Kneba, Hartmut Dohner
Journal: Blood (2004)
Comparing Toxicities and Survival Outcomes with Total Therapy 4 (TT4) for 70-Gene (R70)-Defined Low-Risk Multiple Myeloma (MM) to Results Obtained with Total Therapy 3 Protocols TT3A and TT3B
Authors: Elias J. Anaissie, Frits van Rhee, Antje Hoering, Sarah Waheed, Yazan Alsayed, Nathan Petty, Monica Grazziutti, John Crowley, Bart Barlogie
Journal: Blood (2010)
Reduction of Combined Modality Treatment Intensity in Early Stage Hodgkin’s Lymphoma: Interim Analysis of the HD 10 Trial of the GHSG.
Authors: Volker Diehl, C. Brillant, A. Engert, J. Wolf, L. Nogova, R.-P. Mueller, H. Eich, H.K. Mueller-Hermelink, R. Herrmann, B. Doerken, L. Kanz, R. Greil, B. Pfistner
Journal: Blood (2004)
RBC Transfusions and Iron Chelation Therapy in Clinical Practice in MDS: A One Month Survey by the GFM.
Authors: Christian Rose, A. Stamatoulas, D. Vassilief, S. Brechignac, O. Beyne-Rauzy, F. Courtois, M. Wemeau, Agnes Guerci, M.P. Chaury, B. Lefs, B. Mahe, L. Roy, Bruno Quesnel, F. Dreyfus, Pierre Fenaux
Journal: Blood (2006)
The Impact of the First Exposure to Different Blood Products on the Prevalence and Natural History of Hepatitis C Virus Infection in Von Willebrand Disease (VWD): Results from a Large Cohort Study Comparing VWD and Hemophilia Patients.
Authors: Augusto B. Federici, Mariagrazia Rumi, Elena Santagostino, Antonio Russo, Massimo Colombo, Pier M. Mannucci
Journal: Blood (2004)
Accumulation of Inherited and Acquired Mutations in Hyaluronan Synthase1 Gene May Contribute Oncogenesis in Multiple Myeloma and Waldenstrom’s Macroglobulinemia.
Authors: Sophia Adamia, Jennifer Hodges, Patrick M. Pilarski, Steven Treon, Michael J. Mant, Tony Reiman, Andrew R. Belch, Linda M. Pilarski
Journal: Blood (2006)
Cognitive behavioural therapy and short-term psychoanalytical psychotherapy versus a brief psychosocial intervention in adolescents with unipolar major depressive disorder (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled superiority trial
Authors: Ian M Goodyer, Shirley Reynolds, Barbara Barrett, Sarah Byford, Bernadka Dubicka, Jonathan Hill, Fiona Holland, Raphael Kelvin, Nick Midgley, Chris Roberts, Rob Senior, Mary Target, Barry Widmer, Paul Wilkinson, Peter Fonagy
Journal: The Lancet Psychiatry (2016)

Psychological treatments for adolescents with unipolar major depressive disorder are associated with diagnostic remission within 28 weeks in 65-70% of patients. We aimed to assess the medium-term effects and costs of psychological therapies on maintenance of reduced depression symptoms 12 months after treatment.
Reply to letter to the editor of<i>Gut</i>
Authors: Ji Young Bang, Shyam Varadarajulu
Journal: Gut (2016)

Dear editor,

A systematic review of studies mostly evaluating the role of fully covered self-expandable metal stents (FCSEMS) for drainage of pancreatic fluid collections (PFCs) reported a pooled adverse event rate of 23%.1 To overcome the limitations of FCSEMS and to minimise adverse events, a lumen-apposing metal stent (LAMS) was recently developed. The new stent is a single-step drainage device that is very different in design and mechanics from FCSEMS and hence warranted a change in the terminology, so that …
High Serum Levels of Angiogenic Cytokines in AL Amyloidosis Correlates with Disease Features.
Authors: Efstathios Kastritis, Evangelos Terpos, Mihail Mihail, Konstantinos Anargyrou, Sossana Delimpassi, Marie Christine Kyrtsonis, Evridiki Mihali, Elina Vervessou, Natalia Tzenou, Panagiotis Repoussis, Gerassimos Panagalis, Meletios Athanasios Dimopoulos
Journal: Blood (2007)
Combination Chemotherapy with Rituximab, Gemcitabine, Vinorelbine and Liposomal Doxorubicin As a Salvage Regimen for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Authors: Patrick L Stevens, Mahsa Talbott, Meghan E Caldwell, David S Morgan, Annette S. Kim, John P Greer, Nishitha M. Reddy
Journal: Blood (2011)
Myeloma Treatment Side Effects and Unmet Patient Needs 2009: Results of An International Comparative Survey Conducted by Myeloma Euronet (ME), the European Network of Myeloma Patient Groups.
Authors: Anita Waldmann, Begoña Barragán, Viorica Cursaru, Candy Heberlein, Miroslav Hrianka, Friedrich Richter, Roman Sadżuga
Journal: Blood (2009)
Administration of Rituximab Is Feasible and Does Not Affect Engraftment of Allograft Recipients with Advanced CD20+ Malignancies.
Authors: Mohamed A. Kharfan-Dabaja, Cheryl Tate, Janelle Perkins, Hugo F. Fernandez, Teresa Field, Ernesto Ayala, Lia Perez, Jyotishankar Raychaudhuri, Melissa Alsina, Dan Sullivan, Linda Brand, William Poling, Claudio Anasetti
Journal: Blood (2007)
Longer Follow-Up Confirms a Low Relapse Rate after Non-Myeloablative Allogeneic Transplantation (NMT) for Non-Hodgkin’s Lymphoma (NHL), Including Patients with PET or Gallium-Avid Disease.
Authors: Issa F. Khouri, Rima M. Saliba, Ming-Sheng Lee, Grace-Julia Okoroji, Luis Fayad, Farzaneh Maadani, Chitra Hosing, Barry Samuels, Sergio Giralt, Marcos de Lima, Barbara Pro, Anas Younes, Peter McLaughlin, Larry Kwak, Richard E. Champlin
Journal: Blood (2005)
Effect of Artesunate On Inhibiting Proliferation and Inducing Apoptosis of SP2/0 Myeloma Cells through Affecting NFκB p65.
Authors: Shihui LI, Ling PAN, Fang Xue, Zhiyong Cheng, Xiaoyang Yang, Xiaoling Guo, Suyun Wang
Journal: Blood (2009)
Acute Myeloid Leukemia with Coexpression of Lymphoid-Associated Antigens: Clinicobiological Associations and Prognostic Implications,
Authors: Georgia Voutiadou, Konstantina Kotta, Barbara Tachynopoulou, Apostolia Papalexandri, Chryssanthi Vadikolia, Aliki Tsompanakou, Anastasia Athanasiadou, George Papaioannou, Chrysavgi Lalayanni, Niki Stavroyianni, Antonia Syrigou, Charikleia Kelaidi, Maria Papathanasiou, Ioanna Sakellari, Riad Saloum, Kostas Stamatopoulos, Achilles Anagnostopoulos
Journal: Blood (2011)
Defining the Topography of Deletion 5q Using SNP-A Identifies Patients with More Aggressive Disease and Correlates with Additional Lesions
Authors: Andres Jerez, Anna M Jankowska, Hideki Makishima, Lukasz P Gondek, Ramon V Tiu, Christine L O‘Keefe, Azim M Mohamedali, Denise Batista, Michael A McDevitt, Mikkael A Sekeres, Ghulam J. Mufti, Jaroslaw P Maciejewski
Journal: Blood (2011)
SGN-33, Lintuzumab, Demonstrates Anti-Leukemic Activity in Preclinical Models of AML.
Authors: May S.K. Sutherland, Changpu Yu, Carol Morris-Tilden, Timothy S. Lewis, Jamie B. Miyamoto, Julie A. McEarchern, Ezogelin Oflazoglu, Hanspeter Gerber, Eric L. Sievers, Iqbal S. Grewal, Che-Leung Law
Journal: Blood (2007)
Cytarabine Either with Induction or Conditioning May Improve Outcomes Among Those Undergoing Autologous Transplantation in First or Second Remission for Mantle Cell Lymphoma
Authors: Bijal D. Shah, Bryan J Little, Jennifer Cultrera, Celeste M. Bello, Lubomir Sokol, Eduardo M. Sotomayor, Marcie Tomblyn, Ernesto Ayala
Journal: Blood (2012)
Laparoscopic gastric bypass versus laparoscopic sleeve gastrectomy: A retrospective multicenter comparison between early and long-term post-operative outcomes
Authors: Fabio Rondelli, Walter Bugiantella, Maria Cristina Vedovati, Enrico Mariani, Ruben Carlo Balzarotti Canger, Sara Federici, Adriano Guerra, Marcello Boni
Journal: International Journal of Surgery (2016)
Novel Assay for the Identification of NOTCH1 PEST Domain Mutations Using Fragment Analysis and Allele Specific PCR
Authors: Paulo Vidal Campregher, Roberta Cardoso Petroni, Nair Muto, Rubia Santana, Roberta Sitnik, Oziris P S Ramos, Nydia Bacal, Carolina B Bub, Fabio P S Santos, Perini Guilherme, Helman Ricardo, Clarissa Souza, Reijane Alves de Assis, Gislaine Borba Oliveira, Irene L Metze, Nelson Hamerschlak
Journal: Blood (2012)
Immunoexpression of Macrophage Inflammatory Protein-1 Alpha on Bone Marrow Trephine Biopsies Correlates with the Extent of Bone Disease in Newly Diagnosed Patients with Multiple Myeloma
Authors: Maria Roussou, Anna Tasidou, Efstathios Kastritis, Magdalini Migkou, Maria Gavriatopoulou, Flora Zagouri, Meletios A. Dimopoulos, Evangelos Terpos
Journal: Blood (2008)
Global Sequencing for the Molecular Background of Hereditary Hemochomatosis In Brazilian Patients
Authors: Elvira Maria Guerra-Shinohara, Paulo Caleb Santos, Rodolfo Cancado, Alexandre Pereira, Isolmar Schettert, Renata Soares, Rosario D C Hirata, Mario H Hirata, Regina Pagliusi, Maria Stella Figueiredo, José Eduardo Krieger, Carlos Chiattone
Journal: Blood (2010)
Expression of Human Leukocyte Antigen B61 Is Associated with Idiopathic Aplastic Anemia, Hepatitis-Associated Aplastic Anemia and Fulminant Hepatic Failure in Children
Authors: Yoshiyuki Takahashi, Akira Ohara, Ryoji Kobayashi, Hiromasa Yabe, Akira Kikuchi, Hiroshi Yagasaki, Akira Morimoto, Ken-ichiro Watanabe, Etsuro Ito, Kazuko Kudo, Akinari Fukuda, Seisuke Sakamoto, Mureo Kasahara, Atsuko Nakazawa, Seiji Kojima
Journal: Blood (2012)
Dosimetric Analysis of 90Y-Ibritumomab Tiuxetan (Zevalin®) Given as Consolidation of First Remission in Patients with Advanced-Stage Follicular Lymphoma in the International Phase 3 First-Line Indolent Trial (FIT).
Authors: Angelika Bischof-Delaloye, Cristian Antonescu, Anton Hagenbeek
Journal: Blood (2007)
MT1-MMP Regulates Hematopoiesis Through HIF-Mediated Chemo-/Cytokine Release From the Bone Marrow Niche,
Authors: Chiemi Nishida, Kaori Kusubata, Yoshihiko Tashiro, Ismael Gritli, Aki Sato, Makiko Ohki-Koizumi, Motoharu Seiki, Hiromitsu Nakauchi, Beate Heissig, Koichi Hattori
Journal: Blood (2011)
Biodegradable Magnetic Silica@Iron Oxide Nanovectors with Ultra-Large Mesopores for High Protein Loading, Magnetothermal Release, and Delivery
Authors: Haneen Omar, Jonas G. Croissant, Kholod Alamoudi, Shahad Alsaiari, Ibrahim Alradwan, Majed A. Majrashi, Dalaver H. Anjum, Patricia Martins, Ria Laamarti, Jorg Eppinger, Basem Moosa, Abdulaziz Almalik, Niveen M. Khashab
Journal: Journal of Controlled Release (2016)